Conduit Pharmaceuticals regains Nasdaq compliance

9 hours ago 1

Conduit Pharmaceuticals (NASDAQ:CDT) has regained compliance with Nasdaq’s minimum bid price requirement set forth in Nasdaq Listing Rule, as well as Nasdaq’s stockholders’ equity requirement set forth in Nasdaq Listing Rule.
The Co.’s securities will continue to be listed and traded on The Nasdaq Stock Market.

Recommended For You